SCHEMBL22299026

SCHEMBL22299026

CC(=O)CCCCCC[C@H](CCSCc1ccccc1)SCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 1/20 0.48
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TRPA1 O75762 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ PTGER1 P34995 1/20 0.37
▸ PTGER4 P35408 1/20 0.37
▸ PTGER3 P43115 1/20 0.37
▸ PTGER2 P43116 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.36
▸ MMP1 P03956 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP3 P08254 1/20 0.36
▸ MMP7 P09237 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ MMP13 P45452 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17381367 0.99 CYP2C19 (0.49) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL17973796 0.90 CYP2C19 (0.43) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL22299081 0.89 CYP2C19 (0.58) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL17381514 0.89 CYP2C19 (0.58) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
Cpi 613 SCHEMBL13333201 0.88 CYP2C19 (0.59) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
Cpi 613 SCHEMBL1062218 0.88 CYP2C19 (0.59) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL13333202 0.86 CYP2C19 (0.50) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL16282701 0.85 ALDH1A1 (0.49) CYP2C19ALDH1A1SMN1; SMN2LMNATRPA1
SCHEMBL13333203 0.85 CYP2C19 (0.46) CYP2C19ALDH1A1HPGDSMN1; SMN2LMNA
SCHEMBL14027320 0.84 ALDH1A1 (0.42) CYP2C19ALDH1A1SMN1; SMN2TRPA1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3189033-B1 PHARMACEUTICAL COMPOUNDS RAFAEL PHARMACEUTICALS INC (US) 2020-08-05 — — EP disclosed
Send feedback